JNP
Juniper Pharmaceuticals, Inc. Common Stock
JNP
JNP
Delisted
JNP was delisted on the 13th of August, 2018.
36 hedge funds and large institutions have $9.93M invested in Juniper Pharmaceuticals, Inc. Common Stock in 2014 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 8 increasing their positions, 16 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
59% less call options, than puts
Call options by funds: $156K | Put options by funds: $384K
Holders
36
Holding in Top 10
–
Calls
$156K
Puts
$384K
Top Buyers
| 1 | +$341K | |
| 2 | +$199K | |
| 3 | +$104K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$74.8K |
| 5 |
ARTA
A.R.T. Advisors
New York
|
+$65K |
Top Sellers
| 1 | -$967K | |
| 2 | -$815K | |
| 3 | -$549K | |
| 4 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
-$123K |
| 5 |
RCM
Rotella Capital Management
Bellevue,
Washington
|
-$91K |